Clinical Features	Time to Death		YEARS_TO_BIRTH		NEOPLASM_DISEASESTAGE		PATHOLOGY_T_STAGE		PATHOLOGY_M_STAGE		GENDER	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	Wilcoxon-test_P	Wilcoxon-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
GNAQ	40 (50%)	40	0.22889	1	0.46728	1	0.00181	0.076	0.80115	1	0.051458	0.756	1	1
GNA11	36 (45%)	44	0.28589	1	0.74948	1	0.057499	0.756	0.83389	1	0.30738	1	0.65284	1
EIF1AX	10 (12%)	70	0.43	1	0.41917	1	1	1	0.6667	1	1	1	0.3197	1
SF3B1	18 (22%)	62	0.11463	0.799	0.23056	1	0.88274	1	0.87828	1	0.57284	1	0.59646	1
BAP1	16 (20%)	64	0.84881	1	0.071986	0.756	0.48318	1	0.81214	1	1	1	1	1
PRMT8	5 (6%)	75	0.40162	1	0.13323	0.799	0.11438	0.799	0.38839	1	1	1	0.64879	1
CYSLTR2	3 (4%)	77	0.46374	1	0.42477	1	0.68409	1	0.78296	1	1	1	1	1